Abstract: Visualizing a contaminant is provided. A contaminant of a plurality of different contaminants included in a contaminant knowledgebase is identified based on analysis of contaminant-relevant data received from one or more sensors of a plurality of different sensor arrays regarding an enclosed physical space. A concentration and a type of the contaminant is identified based on the contaminant-relevant data and information included in the contaminant knowledgebase. A location of the contaminant is identified within the enclosed physical space based on location of the one or more sensors that obtained the contaminant-relevant data and a digital twin of the enclosed physical space. A visualization of the contaminant is projected at an area proximate to the location of the contaminant using a holographic image indicating the concentration and the type of the contaminant within the enclosed physical space.

Abstract: A monoclonal antibody, or antigen-binding portion thereof is provided that specifically binds to a region on a mammalian IL-31 protein involved with interaction of the IL-31 protein with its co-receptor, wherein the binding of said antibody to said region is impacted by mutations in a 15H05 epitope binding region selected from: a region between about amino acid residues 124 and 135 of a feline IL-31 sequence represented by SEQ ID NO: 157 (Feline_IL31_wildtype); a region between about amino acid residues 124 and 135 of a canine IL-31 sequence represented by SEQ ID NO: 155 (Canine_IL31); and a region between about amino acid residues 118 and 129 of an equine IL-31 sequence represented by SEQ ID NO: 165 (Equine_IL31). Such antibodies can be in the form of veterinary compositions useful for treating IL-31-mediated disorders in cats, dogs, or horses.

Abstract: Systems and methods for multi-factor authentication of a caller identification (ID) identifier are disclosed. In embodiments, a method includes: receiving, by a computing device of a call recipient, a call request message from a remote caller device of a caller, the call request message including an authentication token shared between the caller and the call recipient, and an identifier; authenticating the caller using the authentication token; saving an authorized caller record in an authorized caller list on the computing device, the authorized caller record including the identifier; receiving an incoming telephone call from the caller, the incoming call including a caller ID identifier; determining that the caller ID identifier matches the identifier in the authorized caller record; and initiating completion of the call based on the determining that the caller ID identifier matches the identifier in the authorized caller record.

Abstract: A method and system for reconstructing magnetic resonance (MR) images, the method including the steps of: receiving an under-sampled MR image, the under-sampled MR image being transformed from under-sampled k-spaced data; classifying intensity of each pixel in the under-sampled MR image to one of a plurality of predetermined quantized values of intensity by using a neural network; and generating a reconstructed MR image based on the classified quantized value of the intensity for each pixel in the under-sampled MR image.

Abstract: A method and system for reducing or removing motion artefacts in magnetic resonance (MR) images, the method including the steps of: receiving a motion corrupted MR image; determining a corrected intensity value for each pixel in the motion corrupted MR image by using a neural network; and generating a motion corrected MR image based on the determined corrected intensity values for the pixels in the motion corrupted MR image.

Abstract: A system determines if a call participant of a call between the call participant and a voice response system is a human or a machine. Responsive to determining that the call participant is a human, an emotional state of the call participant is determined. Environmental information of an environment associated with the call participant is receiving. A receptiveness level of the call participant is determined based upon the emotional state and the environmental information. A message to the call participant is determined based upon the receptiveness level and one or more machine-learning models.

Abstract: A method, system and computer-usable medium are disclosed for updating, upgrading, or performing maintenance on connected devices that includes analyzing usage of the connected devices. A hierarchical representation is formed of the connected devices based on dependency of the devices. Artificial Intelligence/Machine Learning is implemented as to the usage and hierarchical representation to create a model to update or upgrade the connected devices. A schedule is created based on the model that minimizes risk and maximize availability of the connected devices.

Abstract: A method and a system for dataset evaluation are provided. The method can include acquiring a new dataset for integration with an existing dataset. The existing dataset is used to train a machine learning model. The method can also include calculating a baseline of variation for the existing dataset. The baseline of variation can be determined by evaluating various characteristics of the existing dataset. The method can further include determining an output value for the new dataset by also evaluating characteristics of the new dataset. The method can also include comparing the output value to the baseline of variation to generate a variance between the output value and the baseline of variation. The method can further include determining whether the variance is within an acceptable range of the baseline of variation.

Abstract: A method, system and computer-usable medium are disclosed for updating, upgrading, or performing maintenance on connected devices that includes analyzing usage of the connected devices. A hierarchical representation is formed of the connected devices based on dependency of the devices. Artificial Intelligence/Machine Learning is implemented as to the usage and hierarchical representation to create a model to update or upgrade the connected devices. A schedule is created based on the model that minimizes risk and maximize availability of the connected devices.

Abstract: Systems and methods for multi-factor authentication of a caller identification (ID) identifier are disclosed. In embodiments, a method includes: receiving, by a computing device of a call recipient, a call request message from a remote caller device of a caller, the call request message including an authentication token shared between the caller and the call recipient, and an identifier; authenticating the caller using the authentication token; saving an authorized caller record in an authorized caller list on the computing device, the authorized caller record including the identifier; receiving an incoming telephone call from the caller, the incoming call including a caller ID identifier; determining that the caller ID identifier matches the identifier in the authorized caller record; and initiating completion of the call based on the determining that the caller ID identifier matches the identifier in the authorized caller record.

Abstract: An electric motor comprising: a stator assembly; a rotor assembly; and a support body. The stator assembly comprises a plurality of stator elements, and the rotor assembly comprises a shaft to which is mounted at least a first and a second bearing mounted either side of a permanent magnet. The support body comprises an elongate central part, and first and second bearing seats positioned axially at opposite ends of the elongated central part to each other, and the elongate central part defines a plurality of openings each configured to receive one of the plurality of stator elements.

Abstract: Emulsifying salt-free processed cheese products as well as methods of preparing emulsifying salt-free processed cheese products are provided. The emulsifying salt-free processed cheese products are prepared with modified starch containing amylopectin and substantially no amylase and without emulsifying salts. The emulsifying salt-free processed cheese products are advantageously resistant to separation during heating and retain desirable organoleptic properties, such as texture and flavor, without using emulsifying salts.

Abstract: A system determines if a call participant of a call between the call participant and a voice response system is a human or a machine. Responsive to determining that the call participant is a human, an emotional state of the call participant is determined. Environmental information of an environment associated with the call participant is receiving. A receptiveness level of the call participant is determined based upon the emotional state and the environmental information. A message to the call participant is determined based upon the receptiveness level and one or more machine-learning models.

Abstract: An IL-31 dog pruritus model is provided. This model comprises administering canine IL-31 to dogs to produce a pruritic response; quantitatively measuring pruritic responses in the dogs which were administered canine IL-31; administering a candidate dog IL-31 inhibitor; and assessing the effectiveness of the candidate dog IL-31 inhibitor in reducing prurtic behavior in the treated dogs by challenging the dogs with canine IL-31 following the administration of the candidate dog IL-31 inhibitor.

Abstract: A method of treating a dog or cat having an IL-31-mediated pruritic or allergic condition is provided. The method includes administering to the dog or cat a therapeutically effective amount of an isolated antibody that specifically binds to at least one of a canine IL-31 or a feline IL-31.

Abstract: An IL-31 dog pruritus model is provided. This model comprises administering canine IL-31 to dogs to produce a pruritic response; quantitatively measuring pruritic responses in the dogs which were administered canine IL-31; administering a candidate dog IL-31 inhibitor; and assessing the effectiveness of the candidate dog IL-31 inhibitor in reducing prurtic behavior in the treated dogs by challenging the dogs with canine IL-31 following the administration of the candidate dog IL-31 inhibitor.

Abstract: A cell-based assay for assessing the functional activity of a canine or feline IL-31 inhibitor candidate is provided. Such a canine or feline IL-31 inhibitor candidate can be an isolated antibody that specifically binds to at least one of canine Interleukin-31 (IL-31) or feline IL-31. Such antibodies can be in the form of diagnostic and/or veterinary compositions useful for treating a pruritic and/or allergic condition in dogs or cats.

Abstract: A vaccine composition for immunizing and/or protecting a mammal against an IL-31 mediated disorder is provided, wherein the composition includes: the combination of a carrier polypeptide and at least one mimotope selected from a feline IL-31 mimotope, a canine IL-31 mimotope, a horse IL-31 mimotope, and a human IL-31 mimotope; and an adjuvant. Such vaccines can be in the form of pharmaceutical compositions useful for treating or protecting mammals such as cats, dogs, horses, or humans against IL-31-mediated disorders.

Abstract: A monoclonal antibody, or antigen-binding portion thereof is provided that specifically binds to a region on a mammalian IL-31 protein involved with interaction of the IL-31 protein with its co-receptor, wherein the binding of said antibody to said region is impacted by mutations in a 15H05 epitope binding region selected from: a region between about amino acid residues 124 and 135 of a feline IL-31 sequence represented by SEQ ID NO: 157 (Feline_IL31_wildtype); a region between about amino acid residues 124 and 135 of a canine IL-31 sequence represented by SEQ ID NO: 155 (Canine_IL31); and a region between about amino acid residues 118 and 129 of an equine IL-31 sequence represented by SEQ ID NO: 165 (Equine_IL31). Such antibodies can be in the form of veterinary compositions useful for treating IL-31-mediated disorders in cats, dogs, or horses.